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Abstract
Optogenetic approaches using light-activated proteins like Channelrhodopsin-2 (ChR2) enable investigating the function of
populations of neurons in live Caenorhabditis elegans (and other) animals, as ChR2 expression can be targeted to these cells
using specific promoters. Sub-populations of these neurons, or even single cells, can be further addressed by restricting the
illumination to the cell of interest. However, this is technically demanding, particularly in free moving animals. Thus, it would
be helpful if expression of ChR2 could be restricted to single neurons or neuron pairs, as even wide-field illumination would
photostimulate only this particular cell. To this end we adopted the use of Cre or FLP recombinases and conditional ChR2
expression at the intersection of two promoter expression domains, i.e. in the cell of interest only. Success of this method
depends on precise knowledge of the individual promoters’ expression patterns and on relative expression levels of
recombinase and ChR2. A bicistronic expression cassette with GFP helps to identify the correct expression pattern. Here we
show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons. This
approach shall enable to generate strains for optogenetic manipulation of each of the 302 C. elegans neurons. This may
eventually allow to model the C. elegans nervous system in its entirety, based on functional data for each neuron.
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Introduction
Optogenetic approaches to control cellular activity are increas-
ingly used in the neurosciences, to decipher the function of
neuronal populations within neuronal circuits or to precisely
control synaptic transmission and/or plasticity [1–5]. Several
optogenetic tools have been established or generated to date.
These include channelrhodopsins and variants thereof, which are
light-gated cation channels allowing to photodepolarize the
membrane and to activate cells [1,2,6,7]. Halorhodopsin (NpHR)
[8], a light driven chloride importer, and outward directed proton
pumps (Arch and Mac) [9], are used for photohyperpolarization
and thus inactivation of cells. Also light-activated enzymes like
photoactivated adenylate cyclase (PAC) [10–12] to stimulate
intracellular 2
nd messenger signaling, photoswitchable protein tags
like the LOV domain or phototriggered protein-protein interac-
tion modules are used [13,14]. These proteins are generally
expressed using cell-type specific promoters, e.g. those of vesicular
acetylcholine- or GABA transporters, to restrict them to certain
neuronal populations [4]. Further specificity of cell manipulation
may be achieved by selective illumination of the cell of interest,
however, this can be technically demanding [15,16]. Thus,
expression of the optogenetic switch in single cells would be
highly beneficial, as wide-field illumination would still just activate
the cell of interest. In few cases in C. elegans, single-cell specific
promoters have been described that may be employed, but these
are rare, and their utility can be limited as the achievable
expression levels may be too low. A more generic way to achieve
selective expression at high levels is thus needed. This could even
enable ‘‘functional mapping’’ of the C. elegans nervous system in a
neuron-by-neuron manner.
Currently, two main approaches to specifically express proteins
in single cells of C. elegans have been used, both having in common
the use of two promoters with coinciding expression in just the cell
of interest (Fig. 1A): In the first approach, two protein fragments
of the protein of interest are encoded by constructs driven by each
of the two promoters, and reconstitute a functional protein when
co-expressed (Fig. 1B) [17,18]. As there was precedent for
functional reconstitution of bacteriorhodopsin from protein
fragments [19], we attempted to achieve this goal for ChR2 and
NpHR, by splitting the proteins in loops between transmembrane
helices, and attaching leucine zippers and/or split GFP fragments
to the new termini to enhance reconstitution; however, despite
testing numerous split sites, rhodopsin function after in vivo
reconstitution was too low to be useful (Fig. S1). The second
approach (Fig. 1C) uses genetic techniques, where the construct
encoding the protein of interest is conditionally expressed only
when a recombinase removes a transcriptional stop cassette,
flanked by recognition sites for either FLP or Cre recombinase,
which prevents expression of the respective protein. As two
promoters are used for the two constructs, expression is thus found
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(Fig. 1C). Both expression systems have been established for C.
elegans [20,21], and one publication already demonstrated the
application of the FLP system for ChR2 expression in the neuron
pair ASH [22].
Cre is a recombinase from the bacteriophage P1 [23],
recognizing 34 bp DNA sequences termed loxP sites, that removes
or inverts the DNA between them, depending on the orientation of
the loxP sites (Fig. 1C) [24]. Cre is a commonly used tool for both
in vitro and in vivo gene manipulation [25]. The FLP system follows
the same basic principle. FLP recombinase recognizes FRT sites in
the DNA flanking the sequence to be excised (Fig. 1C). Davis et al.
used this to achieve GFP expression cell-specifically [21]. Their
stop cassette contained a red fluorescent marker (mCherry), thus
allowing to follow the expression pattern of the ‘‘off’’ state
expression cassette; the mCherry coding sequence is removed, i.e.
expression abrogated, when FLP activates the expression cassette.
Davis et al. [21] generated constructs based on the Gateway
system, which adds some extra sequence in the reading frame. As
Figure 1. Conditional expression of ChR2 in single neurons using two promoters of intersecting expression domain, and DNA
recombinases. A) Two promoters, each expressing in a different set of neurons, with overlapping expression in one neuron only. B) Concept of
achieving conditional expression using split proteins that can reconstitute functional ChR2 or NpHR in the neuron of interest. See also Fig. S1. C)
Conditional expression is achieved by encoding ChR2 form a construct (driven by promoter I) that is blocked by a transcriptional stop cassette (red
hexagon) between promoter and ChR2 start codon, and is flanked by recombinase recognition sites (loxP or FRT sites, recognized by Cre or FLP
recombinases, respectively). The respective recombinase is driven by promoter II, to generate a transcription-competent DNA construct encoding
ChR2 and (optionally) soluble GFP from a bicistronic expression cassette (via SL2 trans-splicing).
doi:10.1371/journal.pone.0043164.g001
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the final protein.
The main focus of our work is on two pairs of neurons involved
in evoking or generating the backward escape response: ASH and
AVA neurons. Cell bodies of both neuron types are localized in
the nerve ring ganglia in the head [26]. The pair of ASH sensory
neurons extends ciliated dendrites to the nose of the animal. ASH
detects aversive stimuli to the head, including touch, nociceptive
chemicals and osmotic pressure [27]. AVA neurons are command
interneurons that integrate signals from several types of sensory
neurons, mainly in the anterior part of the animal, and among the
other backward command neurons (AVD, AVE) is classified as the
most potent inducer of backward locomotion [28,29]. Here, we
demonstrate expression of ChR2 in AVA backward command
neurons and ASH polymodal sensory neurons, using and
comparing both Cre and FLP recombinase systems. We further
attempted to express ChR2 in the pair of PVC tail neurons, which
are command interneurons leading to a forward movement
[28,30]. While in principle straightforward, the approach can
require a significant amount of empirical optimization. Here we
describe how single-cell expression of ChR2 can be achieved using
either Cre or FLP recombinases, and which critical points need to
be considered. The long-term goal could be to generate, in a joint
effort by many labs, a collection of strains expressing ChR2 and/
or other optogenetic tools in as many single neurons as possible.
Materials and Methods
Strains
C. elegans strains were cultivated on nematode growth medium
(NGM) with the E. coli strain OP50-1. The following genetic
backgrounds were used: N2 (wild type), lite-1(ce314), lin-15(n765ts);
lite-1(ce314). We also used the transgenic strain AQ2334: lite-
1(ce314); ljIs123[pmec-4::ChR2(codon optimized); Punc-122::rfp], a kind
gift of W. Schafer (MRC Laboratory of Molecular Biology,
Cambridge, UK). To create the transgenic ChR2 expression
worm lines the plasmids described below were injected into the
gonads of hermaphrodite animals [31]. Plasmids containing the
recombinase recognition site-flanked ChR2 and plasmids contain-
ing the recombinase were co-injected, at concentrations listed
below. In one case we integrated the extrachromosomal array
using trimethyl-oxalen (Sigma Aldrich) and irradiation with
365 nm UV light [22].
These transgenic strains were prepared: ZX1019: lin-
15(n765ts); lite-1(ce314); zxEx716[pglr-1::loxP::LacZ::STOP::loxP::
ChR2::mCherry::SL2::GFP (80 ng/ml); pgpa-14::Cre (80 ng/ml); lin-
15+], ZX1020: lin-15(n765ts); lite-1(ce314); zxEx704[pflp18::lox-
P::LacZ::STOP::loxP::ChR2::mCherry::SL2::GFP (80 ng/ml); pgpa-
14::Cre (80 ng/ml); lin-15+], ZX1021: lin-15(n765ts); lite-1(ce314);
zxEx705[posm-10::loxP::LacZ::STOP::loxP::ChR2::mCherry:: SL2::GFP
(80 ng/ml); pgpa-11::Cre (80 ng/ml); lin-15+], ZX1023: lin-
15(n765ts); lite-1(ce314); zxIs30[pflp-18::loxP::LacZ::STOP::loxP::
ChR2::mCherry::SL2::GFP (80 ng/ml); pgpa-14::Cre (80 ng/ml); lin-
15+], ZX1084: lin-15(n765ts); lite-1(ce314); zxEx707[p-flp18::lox-
P::LacZ::STOP::loxP::ChR2::mCherry::SL2::GFP (80 ng/ml); prig-3::Cre
(80 ng/ml); lin-15+], ZX1085: lin-15(n765ts); lite-1(ce314);
zxEx711[posm-10::loxP::LacZ::STOP::loxP::ChR2::mCherry:: SL2::GFP
(80 ng/ml); pnhr-79::Cre (150 ng/ml); lin-15+], ZX1379: lin-
15(n765ts); lite-1(ce314); zxEx715[psra-6::loxP::LacZ::STOP::loxP::
ChR2::mCherry::SL2::GFP (150 ng/ml); pnhr-79::Cre (150 ng/ml); lin-
15+], ZX1380: lin-15(n765ts); zxEx717[pflp-18::FRT::mCherry::S-
TOP::FRT::ChR2YFP (80 ng/ml); prig-3::FLP (80 ng/ml); lin-15+],
ZX1394: N2; zxEx718[pglr-1::loxP::LacZ::STOP::loxP::ChR2::
mCherry (80 ng/ml); pdes-2::Cre (80 ng/ml)], ZX1395: N2; zxEx719
[pnmr-1::loxP::LacZ:: STOP::loxP::ChR2::mCherry (80 ng/ml); pdes-
2::Cre (80 ng/ml)], N2; zxEx [pCS1 (100 ng/ml), pCS2 (100 ng/
ml); rol-6d (80 ng/ml)], N2; zxEx [pCS1+ (20 ng/ml), pCS2
(20 ng/ml); rol-6d (80 ng/ml)], N2; zxEx [pCS1+ (100 ng/ml),
pCS6 (100 ng/ml); rol-6d (80 ng/ml)], N2; zxEx [pCS3 (100 ng/
ml), pCS4 (100 ng/ml); rol-6d (80 ng/ml)], N2; zxEx [pCS5 (50 ng/
ml), pCS6 (50 ng/ml); rol-6d (80 ng/ml)], N2; zxEx [pCS10 (50 ng/
ml); rol-6d (80 ng/ml)]
N2; zxEx [pCS14 (100 ng/ml), pCS16 (100 ng/ml); rol-6d
(80 ng/ml)], N2; zxEx [pCS14+ (100 ng/ml), pCS16 (100 ng/ml);
rol-6d (80 ng/ml)], N2; zxEx [pAG54 (100 ng/ml); rol-6d (80 ng/
ml)]
N2; zxEx [pmyo-3::NpHR::eCFP (50 ng/ml); rol-6d (80 ng/
ml)], lin-15(n765ts); zxEx [pCS20 (50 ng/ml), pCS23 (50 ng/ml);
lin-15+ (80 ng/ml)], lin-15(n765ts); zxEx [pCS21 (50 ng/ml),
pCS24 (50 ng/ml); lin-15+ (80 ng/ml)], lin-15(n765ts); zxEx
[pCS21 (50 ng/ml), pCS24+ (50 ng/ml); lin-15+ (80 ng/ml)], lin-
15(n765ts); zxEx [pCS22 (50 ng/ml), pCS25 (50 ng/ml); lin-15+
(80 ng/ml)]
lin-15(n765ts); zxEx [pCS26 (50 ng/ml); lin-15+ (80 ng/ml)], lin-
15(n765ts); zxEx [pCS27 (50 ng/ml); lin-15+ (80 ng/ml)], lin-
15(n765ts); zxEx [pCS28 (50 ng/ml); lin-15+ (80 ng/ml)]
lin-15(n765ts); zxEx [pCS83 (50 ng/ml), pCS85 (50 ng/ml); lin-
15+ (80 ng/ml)], lin-15(n765ts); zxEx [pCS80 (50 ng/ml), pCS82
(50 ng/ml); lin-15+ (80 ng/ml)], lin-15(n765ts); zxEx [pCS81
(50 ng/ml), pCS82 (50 ng/ml); lin-15+ (80 ng/ml)], lin-15(n765ts);
zxEx [pCS89+ (50 ng/ml), pCS90+ (50 ng/ml); lin-15+ (80 ng/
ml)], lin-15(n765ts); zxEx [pCS89+ (50 ng/ml), pCS91+ (50 ng/ml);
lin-15+ (80 ng/ml)], lin-15(n765ts); zxEx [pCS92 (50 ng/ml),
pCS94 (50 ng/ml); lin-15+ (80 ng/ml)]
Plasmids
The following plasmids were kindly provided by N. Pokala
(Bargmann lab, Rockefeller University, USA): pNP165: Pglr-
1::flox::ChR2::mCherry, pNP259: Pgpa-14::Cre, pNP260: Pnmr-
1::flox::ChR2::mCherry. Plasmids pWD172 (Entry-Vector for
Slot-2 in Gateway cloning containing FLP) and pWD178 (Entry-
Vector for Slot-2 in Gateway cloning containing FRT::mCher-
ry::STOP::FRT) were kindly provided by E. Jorgensen [21]. The
plasmid pTNZ126 (containing FLP::unc-54-UTR) was a kind gift
from W. Schafer. In addition, these plasmids were kindly
provided: TU#712 (nzYFP=YFP(aa1-157)::zipper); TU#715
(czCFP=zipper::CFP(aa155-239)) (gifts by M. Chalfie [17]);
spGFP1-10 (GFP(aa1-214)); spGFP11 (pat-3-signalpeptide::
GFP(aa215-230)) (gifts by C. Bargmann [32]). Plasmids pAG54
(pmyo-3::ChR2::YFP) and pmyo-3::NpHR::eCFP were described
previously [1,8].
The following plasmids were prepared in this work: pCoS2
(pnhr-79::Cre): As backbone, plasmid pNP259, cut with SphI and
XmaI, was used. The inserted nhr-79 promoter was amplified from
genomic DNA using oligos CAAGCTTGCATGCGCGGATA-
GACT TCCAGTTGTGAAT and CCATGGTACCGTC-
GATTTTATGCTAAAAATCGATAAATCAAGG. The insert
was cloned using the In-Fusion Cloning Kit (CloneTech, USA).
pCoS3 (psra-6::loxP::LacZ::STOP::loxP::ChR2::mCherry): As
backbone, plasmid pNP165, cut with FseI and AscI, was used.
The sra-6 promoter was amplified from psra-6::ChR2::YFP using
oligos GCGGCCAAACATGATCTTAC and CATACC-
TTTGGGTCCTTTGG. pCoS6 (pglr-1::loxP::LacZ::STOP::
loxP::ChR2::mCherry::SL2::GFP): To insert coding sequence for
bicistronically expressed GFP into plasmid pNP165, an AvrII
restriction site was added after ChR2::mCherry by site-directed
mutagenesis; then the plasmid was opened using AvrII. The insert
for bicistronically expressed GFP was amplified from plasmid
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Molecular Biology, Cambridge, UK) using oligos GGACC-
CAAAGGTATGTTTCG and TTAGGTACTAGTCGCTCA-
GTTGGAATTCTACG. pCoS10 (pflp-18::loxP::LacZ::STO-
P::loxP::ChR2::mCherry::SL2::GFP): pCoS6 was cut with SphI
and BamHI, then the flp-18 promoter was inserted after
amplification from plasmid pCS40 using oligos AAGCTTGG-
CCGGCCTCTGTCACATACTGCTCGAATC and AAGCTT
GGCGCGCCGTCTAACCCTGAAATTATTATTTTTAGTTG.
pCoS11 (prig-3::Cre): Plasmid pNP259 was cut with SphI and
XmaI, and the rig-3 promoter was inserted after amplification
from plasmid pCS42 using the oligos AAGCTTGGCCGGCC-
TTCTCTGCCTCCCTCAACTTC and AAGCTTGGCG-
CGCCTTTCGAAAAAGAAGAATGAAGTTCTTC. pCoS13
(posm-10::loxP::LacZ::STOP::loxP:: ChR2::mCherry::SL2::GFP):
Plasmid pCoS6 was cut with SphI and BamHI, and the posm-10
promoter inserted after amplification from plasmid pKS52 (posm-
10::GFP; a gift by Anne Hart, Brown University, USA) using
oligos GAATTGCATGCTGCGCCTTTGAAGAGTACTG and
AATTGTCGACCGAAAGTTGGCT CAACATCTC. pCS40
(pflp-18::FRT::mCherry::STOP::FRT::ChR2::YFP): Plasmids
pCS45, pCS49, and pCS48 were conjointly used in a Gateway
recombination reaction with the vector pDESTR4-R3 (Invitrogen)
to generate pCS40. pCS41 (prig-3::FRT::mCherry::STOP::FRT::
ChR2::YFP): Likewise, plasmids pCS46, pCS49, and pCS48 gave
rise to pCS41 in a Gateway recombination reaction with vector
pDESTR4-R3 (Invitrogen). pCS45 (pflp-18 entry-Vector for Slot-
1 in Gateway cloning): A ,4,2 kbp fragment of the promoter pflp-
18 was amplified from genomic C. elegans DNA by PCR using
oligos oCS95 (GGGGACA ACTTTGTATAGAAAAGTTGGC-
TCTGTCACATACTGCTCG) and oCS96 (GGGGACTGC T-
TTTTTGTACAAACTTGGCATGTCTAACCCTGAAA). The
purified PCR product was then used in a recombination reaction
with pDONR-P4-P1r and BP Clonase II (Invitrogen) to generate
pCS45. pCS46 (prig-3 Entry-Vector for Slot-1 in Gateway
cloning): A ,3,1 kbp fragment of the promoter prig-3 was
amplified from genomic DNA by PCR using the oligos oCS93
(GGGGACAACTTTGTATAGAAAAGTTGGCTTCTCTGC-
CTCCCTCAACTTC) and oCS94 (GGGGACTGCTTTTTTG-
TACAAACTTGGCATTTTCGAAAAAGAAGAATGAAG). The
purified PCR product was recombined with pDONR-P4-P1r
using BP Clonase II (Invitrogen). pCS47: (unc-54 39-UTR, Entry-
Vector for Slot-3 in Gateway cloning): ,0,8 kbps of the unc-54-
UTR were PCR amplified from pAG54 [3], using oligos oCS99
(GGGGACAGCTTTCTTGT ACAAAGTGGGCTAACATC-
TCGCGCCCGTGCCTC) and oCS101 (GGGGAC-
AACTTTG TATAATAAAGTTGGCGGCCGACTAGTAG-
GAAACAG). The purified PCR product was then used in a
recombination reaction with pDONRP2R-P3 and BP Clonase II
(Invitrogen) to generate pCS47. pCS48 (ChR2::YFP::unc-54-
UTR, Entry-Vector for Slot-3 in Gateway cloning): A ,2,6 kbp
fragment containing ChR2::YFP::unc-54UTR was PCR ampli-
fied from pAG54 [1] using oligos oCS100 (GGGGA-
CAGCTTTCTTGTACAAAGTGGGCGCATG GATTATG-
GAGGCGCCC) and oCS101 (GGGGACAACTTTGTATA-
ATAAAGTTGGCGGC CGACTAGTAGGAAACAG). The pu-
rified PCR product was then recombined with pDONRP2R-P3.
pCS49 (FRT::mCherry::STOP::FRT, Entry-Vector for Slot-2 in
Gateway cloning): A ,1,5 kbp fragment containing FRT::
mCherry::STOP::FRT was PCR amplified from pWD178 [21]
using oligos oCS97 (GGGGACAAGTTTGTACAAAAAAG-
CAGGC) and oCS98 (GGGGACCACTTTGTACAAGAAAG-
CTGGGTCGAAGTTCCTATACTTTCTAG). The purified
PCR product was then recombined with pDONR221. pCS101
(pflp-18::FLP): A ,4,2 kbp fragment of pflp-18 was amplified from
pCS45 using oligos oCS200 (GTGGATCCGCTATCAACTTT-
GTATAGAAAAGTTG) and oCS205 (CACAGCTAGCGT
CTAACCCTGAAATTATTATTT) and cloned into pTNZ126
using BamHI and BmtI cuts. pCS102 (prig-3::FLP): A ,3,1 kbp
fragment of prig-3 was amplified from pCS46 by PCR using the
oligos oCS200 (GTGGATCCGCTATCAACTTTGTATAGAA-
AAGTTG) and oCS203 (CACAGCTAGCTTTCGAAAAA-
GAAGAATGAAG). The purified PCR product was then ligated
into pTNZ126 after BamHI and BmtI restricition. pCS132 (prig-
3::FRT::mCherry::STOP::FRT::ChR2::YFP): ,1,5 kbp contain-
ing FRT::mCherry::STOP::FRT were amplified from pCS49
using oligos oCS229 (GTGTGCTAGCACCGGTGGGCCC-
GAAG TTCCTATTCTCTAGAAAG) and oCS230 (CA-
CAGGGGCCCGAAGTTCCTATACTTTCTAG), and subse-
quently digested with a) AgeI and EcoRV (resulting in a
0,8 kbp fragment) and b) EcoRV and EcoO109I (resulting in
0,6 kbp fragment). In addition, a ,2,5 kbp fragment containing
ChR2::YFP::unc-54-39-UTR was amplified from pAG54 [1] by
PCR using oligos oCS231 (GTGTGGGCCCCATGGATTATG-
GAGGCGCCCTG) and oCS232 (GGGCCCGTAC GGCCG-
AC) and digested with EcoO109I and BsiWI. All three fragments
were then cloned into pCS102 using the restriction enzymes AgeI
and BsiWI. pCS133 (pgpa-14b::FLP): A ,3,0 kbp fragment of
pgpa-14b was amplified from genomic DNA using oligos oCS236
(GTGTCCTGCAGGACGACGACAAGAAGGTAATT) and
oCS237 (CACAGCTAGCTACA CCTGAATTTTATAAG),
and subcloned into pTNZ126 following SbfI and BmtI digestion.
pCS134 (pglr-1::FLP): A ,5,3 kbp fragment ofthe promoter pglr-1
was amplified from pCS106 [33] by PCR using the oligos oCS233
(CATGCCTGCAGGGGCCGGCCGTAGCCGGTATG) and
oCS234 (CACAGCTAGCC TGTGAATGTGTCAGATTGG).
The purified PCR product was then cloned into pTNZ126 using
SbfI and BmtI. pCS135 (pgpa-14b::FRT::mCherry::STOP::
FRT::ChR2::YFP): ,3,0 kbps of pgpa-14b were amplified from
pCS133 using oligos oCS236 (GTGTCCTGCAGGACGACGA-
CAAGAAGGTAATT) and oCS238 (CACAACC GGTTA-
CACCTGAATTTTATAAG), and cloned into pCS132 after
SbfI and AgeI digest. pCS136 (pglr-1::FRT::mCherry::STOP::
FRT::ChR2::YFP): A ,5,3 kbp fragment of the promoter pglr-1
was amplified from pCS134 using oligos oCS233 (CATGCCTG-
CAGGGGCC GGCCGTAGCCGGTATG) and oCS235 (CA-
CAACCGGTCTGTGAATGTGTCAGATTGG). The purified
PCR product was then cloned into pCS132 using restriction
enzymes SbfI and BmtI. pSH116 (pdes-2::Cre): Plasmid pNP259
was cut with SphI and NcoI and the des-2 promoter inserted after
amplification from genomic DNA using oligos ACGTAG-
CATGCGATC TCAAAGTACATACATTC and ATCCAT-
GGCCTGTAGTAAAAGTAAATGTG.
The first 29 amino acids of the ChR2 primary structure were
recognized as eukaryotic signal sequence by computational
analysis (SignalP [34]) and were referred to as ChR2-signal
sequence. Similarly, using an alternative upstream start codon
within the genome of Natronomonas pharaonis added additional 19
amino acids to the amino-terminus which were recognized as
eukaryotic signal peptide, again using SignalP. This sequence was
cloned into plasmid pCS10: pmyo-3::NpHR-SigSeq::NpHR::eCFP
[35], and termed NpHR-signal sequence. Sites of fragmentation
within ChR2(H134R) and NpHR were selected in loop-regions in
order to minimize impact on functionality of the respective
rhodopsin. To this end, the primary structures of ChR2(H134R)
and NpHR were aligned with the homologous bacteriorhodopsin
[36] and Halorhodopsin structures [37] from Halobacterium
salinarium – using the tools ClustalW [38], HMMTOP [39],
Conditional Expression of ChR2 in C. elegans
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information about ChR2(H134R) was contributed by P. Wood
and E. Bamberg and for NpHR by L. Forrest (all Max-Planck
Institute for Biophysics). The topology of individual fragments was
analyzed using the algorithms of TMHMM [42] and SOSUI [43].
The following plasmids were generated using standard techniques:
pCS1: pmyo-3::nzYFP::ChR2 (Helices3-7; Ala111-Thr314),
pCS1+: pmyo-3::ChR2-SigSeq::nzYFP::ChR2 (Helices3-7;
Ala111-Thr314), pCS2: pmyo-3::ChR2 (Helices1-2; Met1-
Leu110)::czCFP, pCS3: pmyo-3::nzYFP::ChR2 (Helices4-7;
Asn143-Thr314), pCS4: pmyo-3::ChR2 (Helices1-3; Met1-
Ser142)::czCFP, pCS5: pmyo-3::NpHR-SigSeq::NpHR::eCFP,
pCS6: pmyo-3::ChR2 (Helices1-5; Met1-Gly206)::czCFP,
pCS14: pmyo-3::NpHR (Helices1-3; Met1-Ser144), pCS14+:
pmyo-3::NpHR-SigSeq::NpHR (Helices1-3; Met1-Ser144),
pCS16: pmyo-3::NpHR (Helices 4-7; Ser144-Asp291)::eCFP,
pCS20: pmyo-3::ChR2 (Helix 1, Met1-Thr74), pCS21: pmyo-
3::ChR2 (Helices 1-2, Met1-Pro105), pCS22: pmyo-3::ChR2
(Helices 1-5, Met1-Gly199), pCS23: pmyo-3::ChR2 (Helices 2-7,
Lys76-Thr314), pCS24: pmyo-3::ChR2 (Helices 3-7, Ser106-
Thr314), pCS24+: pmyo-3::ChR2-SigSeq::ChR2 (Helices 3-7,
Ser106-Thr314), pCS25: pmyo-3::ChR2 (Helices 6-7, Tyr200-
Thr314), pCS26: pmyo-3::ChR2 (Helix 1, Met1-
Thr74)::YFP::ChR2 (Helices 2-7, Trp75-Thr314), pCS27: pmyo-
3::ChR2 (Helices 1-2, Met1-Pro105)::YFP::ChR2 (Helices 3-7,
Ser106-Thr314), pCS28: pmyo-3::ChR2 (Helices 1-5, Met1-
Gly199)::YFP::ChR2 (Helices 6-7, Tyr200-Thr314, pCS80:
pmyo-3::NpHR (Hel. 1-2; Met1-Gly88), pCS81: pmyo-
3::NpHR-SigSeq::NpHR (Hel. 1-2; Met1-Gly88), pCS82:
pmyo-3::NpHR (Hel. 3-7; Leu89-Asp291)::eCFP, pCS83: pmyo-
3::NpHR (Hel. 1; Met1-Pro62), pCS85: pmyo-3::NpHR
(Hel. 2-7; Arg63-Asp291)::eCFP, pCS89+: pmyo-3::pat-3 Sig-
Seq::spGFP11:: NpHR (Hel. 3-7; His100-Asp291), pCS90+:
pmyo-3::NpHR (Hel. 1-2; Met1-Gly99)::spGFP1-10, pCS91+:
pmyo-3::NpHR SigSeq::NpHR (Hel. 1-2; Met1-Gly99)::
spGFP1-10, pCS92: pmyo-3::NpHR (Hel. 1-2; Met1-Gly99),
pCS94: pmyo-3::NpHR (Hel. 3-7; His100-Asp291)::eCFP
Fluorescence Microscopy
Expression of ChR2 with bicistronically expressed GFP using
the described promoter combinations and also the
ChR2::mCherry expression were analyzed on an LSM confocal
laser scanning microscope, as well as on a Zeiss Axio Observer
equipped with a Marianas spinning-disk confocal (SDC) system (3i
- Intelligent Imaging Innovations) and an Evolve EMCCD camera
(Photometrics).
Behavioral Assays
To minimize light induced escape behavior, i.e. not mediated by
ChR2, all experiments were performed in a mutant background,
lite-1(ce314), which is largely insensitive to blue and UV light
[44,45], and thus shows almost no negative phototaxis.
Response Tests. Transgenic worms were cultivated in the
dark at 20uC on NGM plates with OP50-1 bacteria with or
without all-trans retinal (ATR). Plates containing ATR were
prepared by spreading 300 ml of OP50-1 culture mixed with 0.3 ml
of 100 mM ATR stock (dissolved in ethanol) onto 5.5-cm plates
containing 8 ml of NGM. About 18 h before the experiments, L4
larvae, grown on ATR plates, were placed on fresh ATR plates.
For the measurements worms were illuminated on 5.5-cm
diameter plates containing 8 ml of NGM with blue light
(1.6 mW/mm
2) from a 100-W mercury lamp, filtered through a
GFP excitation filter (450–490 nm), under a 106objective on an
Axiovert 200 microscope (Zeiss, Germany). Duration of illumina-
tion was defined by a computer-controlled shutter (Sutter
Instruments, USA). Every single worm was illuminated 5 times
for 1 s with an ISI (interstimulus interval) of 10s and afterwards the
mean of all 5 illuminations was generated. Any observable
backward locomotion during or directly after (1 s) a blue light
pulse was counted as a response.
Patterned Illumination. All worms tested were F1 progeny
of P0 adults picked onto ATR plates 4 d before experiments.
Young adult worms were picked onto NGM plates with a thin
layer of OP50 with ATR 25 min before the experiments. Strains
with non-integrated transgenes were picked on the basis of a
fluorescent co-injection marker. Each animal was used only for a
single experiment and then discarded. Animals were illuminated 3
times for 2 s with an ISI of 10 s and the mean of all 3 illuminations
was calculated. The patterns included head region (anterior 17%),
the region directly posterior of the head (17–30%) and the whole
animal. The measurement and velocity analysis was conducted as
described [15].
Analyses of contraction and relaxation. These effects were
taken as indication for functional reconstitution of complementary
ChR2 and NpHR fragments, respectively, were essentially
performed as described previously [8]. In short, animals were
recorded on non-seeded NGM plates using an Axiovert 40 CFL
microscope (Zeiss) with 106magnification and Powershot G5 or
G9 digital cameras (Canon). For photoactivation, yellow light
(530–560 nm; 10.2 mW/mm
2; filter F41-007, AHF Analysetech-
nik) or blue light (450–490 nm; 1.6 mW/mm
2; filter F36-525,
AHF Analysetechnik) from an HBO50 light source were presented
and controlled by a computer-driven shutter (Sutter Instruments).
Videos were then extracted into single frames and worm length
(after 560 ms photostimulation) was analyzed using a custom
written script for Matlab [4] or ImageJ.
Results
Specific Expression of ChR2 in PVC Using the Cre-loxP
System
Two genetic constructs are required to achieve single cell
expression of a protein via this system in C. elegans: One encodes
Cre, driven by one promoter, and the second one uses another
promoter, instructing expression of the protein of interest, in this
case ChR2 (Fig. 1). A transcriptional stop cassette (also encoding
LacZ) is included between promoter and the protein of interest,
flanked by loxP sites [20]. Therefore, ChR2 can only be expressed
at the ‘‘intersection’’ of both chosen promoters. The target
construct after recombination will contain the promoter, one loxP
site, start codon (ATG) and coding sequence for ChR2::mCherry.
First we tried to achieve specific ChR2 expression in the PVC
command interneurons. These cells evoke forward locomotion
when being photostimulated by selective illumination of the tail in
a strain expressing ChR2 from the glr-1 promoter that, however, is
active in many additional neurons [46,47]. To enable this using
wide-field illumination, we attempted to express ChR2 specifically
in this cell pair, for which no single-cell specific promoter is
known. Promoter pairs potentially overlapping in this cell, or in
any given neuron, can be deduced from the literature, i.e. as data
deposited in wormbase (www.wormbase.org), and conveniently
summarized for each cell in Nikhil Bathla’s online tool ‘‘C. elegans
interactive neural network’’ (www.wormweb.org/neuralnet#c=
PVC&m=1). Based on this repository, we chose two different
promoter pairs: pglr-1/pdes-2 and pnmr-1/pdes-2 (Table 1). Cre
recombinase was placed under the control of the des-2 promoter,
while the loxP::LacZ::STOP::loxP::ChR2::mCherry construct was
placed downstream of either the glr-1 or the nmr-1 promoter. The
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the pattern of pglr-1 only [30] (Fig. 2A). The promoter pair pnmr-
1/pdes-2 led to an expression of ChR2 in PVC in the tail but also
in four additional cells in the head: AVA, AVD, AVE and RIM
(Fig. 2B, C), i.e. essentially the expected pnmr-1 expression
pattern. The animals were not further tested in optogenetic
behavioral assays, as the multitude of neurons expressing ChR2
would have caused too many cells to be activated concomitantly.
PVC could be selectively photostimulated by patterned illumina-
tion of pglr-1::ChR2 animals, leading to acceleration of the animals
[46,47]. Thus, despite predicted overlap of expression patterns in
PVC, the chosen promoter combinations resulted in expression
more closely resembling the glr-1 or the nmr-1 promoters. Possibly,
expression patterns described in the literature are rather
incomplete, thus Cre may be expressed in many more cells than
only those described for the des-2 promoter.
Specific expression of ChR2 in ASH neurons
To study the integration of ASH sensory neurons into the C.
elegans nervous system, e.g. at the level of the interneurons, a
possibility to specifically photostimulate ASH neurons would be
desirable. We used the promoter combinations psra-6/pnhr-79,
posm-10/pgpa-11 and posm-10/pnhr-79 (Table 2) to achieve ChR2
expression in ASH with Cre recombinase. Here, we generated
constructs that would allow expressing ChR2::mCherry, and
additionally, from a bicistronic expression cassette, soluble GFP as
a bright fluorescent marker, enabling to better visualize all cells
likely to express ChR2. The ChR2::mCherry signal is relatively
weak and clustered, thus it is difficult to unequivocally identify
individual neurons via ChR2::mCherry only. While psra-6/pnhr-79
lines showed no visible expression, posm-10/pgpa-11 lines featured
high GFP fluorescence in ASH but also a similar fluorescence in
the ASI neuron (Fig. 3A), another amphid neuron in the head
[48]. The use of the promoter pair posm-10/pnhr-79 essentially
resulted in a specific expression of ChR2 in ASH, but there was
also an expression in PHB, a tail phasmid neuron [49] (Fig. 3B).
Thus, neither of these promoter pairs led to an exclusive ASH
specific expression. Yet, with patterned illumination, the latter
combination would allow specific ASH (or PHB) photostimulation.
In behavioral assays we tested the posm-10/pgpa-11 and posm-10/
pnhr-79 lines together with animals expressing ChR2 in the
mechanoreceptor neurons (pmec-4::ChR2) as a positive control;
these animals are known to reverse upon photostimulation [1]. All
behavioral assays were performed in a lite-1(ce314) genetic
background, to eliminate the intrinsic photophobic response of
C. elegans. As a negative control, we used animals without any
ChR2 expression (Fig. 3D). Only 35% of the posm-10/pgpa-11
and 24% of the posm-10/pnhr-79 animals responded to blue light
illumination with a reversal, a value which was significantly above
the negative control (8%). With the promoter pairs tested, it was
thus not possible to achieve ChR2 expression which was exclusive
for ASH and produced a robust blue light reaction. Meanwhile
Ezcurra et al. established a worm strain (AQ2235) expressing
ChR2 exclusively in ASH by using the FLP recombinase system
with a different promoter pair, psra-6/pgpa-13 [22]. We took
confocal images of these animals (a kind gift by W. Schafer) and
tested them in behavioral assays (Fig. 3C, D). Strain AQ2235
shows a visible ChR2::YFP expression in the ASH neurons only
and 98% of these animals responded with withdrawal to a blue
light stimulus. We thus did not further try to optimize our own
efforts to generate such animals and suggest to use AQ2235
animals in future experiments where specific ASH stimulation is
needed.
Expression of ChR2 in AVA Using the FLP-System
We next tested conditions allowing expression of ChR2
specifically in AVA backward command neurons using either
the FLP or the Cre (see below) recombinase systems. To express
ChR2 in AVA using FLP recombinase, we used the promoter
pairs pglr-1/pgpa-14,p gpa-14/pglr-1, prig-3/pflp-18, and pflp-18/
prig-3 (Table 3). We first used Gateway cloning, as for the
constructs originally described by Davis et al. (2008) [21].
However, this results in additionally translated sequence that can
interfere with the function of the proteins expressed. Thus, we also
used conventional cloning techniques, which in our hands led to
better results. We also added individual start codons for each
mCherry and ChR2::YFP. Only when we used conventional
Figure 2. Promoter combinations chosen for expression of
ChR2 in PVC neurons, using Cre recombinase, are not PVC-
specific. A) Confocal stack of an animal expressing ChR2::mCherry in
head neurons and PVC, using the glr-1 and des-2 promoters, resembling
the pglr-1 expression pattern. B) The promoter combination nmr-1 and
des-2 led to an expression in four neurons in the head (AVA, AVB, AVD,
AVE), in addition to expression in PVC in the tail (C). Scale bars=20 mm.
doi:10.1371/journal.pone.0043164.g002
Table 1. Promoter combinations used for PVC specific ChR2 expression (Cre-lox system).
Promoter Expression pattern Combinations
pglr-1 AIB, AVA, AVB, AVD, AVE, AVG, AVJ, DVC, PVC,
PVQ, RIG, RIM, RMD, SMD, URY [62]
pglr-1::loxP::LacZ::STOP::loxP::
ChR2::mCherry
pdes-2 m1 head muscles, IL2, FLP, PVD, PVC [63] pdes-2::Cre
pnmr-1 AVA, AVE, AVG, PVC, DVA and one of: RIM, AVH,
AVD, AVB [62]
pnmr-1::loxP::LacZ::STOP::
loxP::ChR2::mCherry
Expression pattern similar
to pglr-1 pattern
Expression in PVC and four additional
cells
doi:10.1371/journal.pone.0043164.t001
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notable expression of ChR2::YFP in AVA, i.e. pflp-
18::ChR2::YFP/prig-3::FLP (Fig. 4A). cDNA encoding mCherry
was inserted in the stop cassette, based on the constructs by Davis
et al. (2008) [21], such that cells in which pflp-18 is expressed, and
in which FLP recombinase was not active, showed red fluores-
cence (Fig. 4A, bottom). In contrast, FLP recombinase expression
activated ChR2::YFP expression, leading to visible YFP fluores-
cence, in AVA, but also in other cells, most likely M2 and RIM
(Fig. 4A, top). Subsequently, we tested the withdrawal reaction of
these animals to a blue light stimulus. The pflp-18::ChR2::YFP/prig-
3::FLP line showed withdrawal behavior in 49% of the animals
tested (Fig. 4B). However, as additional cells expressed
ChR2::YFP in these animals, we cannot conclude that the
behavior was purely evoked by AVA neurons. As the other lines
did not visibly express ChR2, we did not test them in behavioral
assays.
Specific expression of ChR2 in AVA neurons using the
Cre-loxP System
As we could not achieve specific expression in AVA using the
promoters described and FLP recombinase, we turned to the Cre
recombinase and an additional promoter combination. Accord-
ingly, we tested these three promoter pairs: pglr-1/pgpa-14,p flp-
18/prig-3, and pflp-18/pgpa-14 (Table 4). To better visualize the
cells, ChR2::mCherry was again linked to GFP in a bicistronic
cassette. The combination of pglr-1 and pgpa-14 led to an
expression in 10 different cells and was thus not specific for
Figure 3. Expression pattern and behavioral responses of animals generated towards ChR2 expression in ASH by using Cre
recombinase. GFP fluorescence (confocal stacks) in animals expressing ChR2::mCherry and GFP (bicistronically co-expressed) using the promoter
combinations osm-10 and gpa-11 A), osm-10 and nhr-79 B), or sra-6 and gpa-13 C). Scale bar=20 mm. D) Behavioral assay testing withdrawal
reactions in response to 470 nm blue light illumination of the indicated conditional expression strains (all lite-1(ce314) background). Strain AQ2334
(pmec-4::ChR2) and lite-1(ce314) were used as positive and negative controls, respectively. n=14 animals of each strain were tested, with 5
consecutive light pulses each; displayed are means 6 SEM. Stastistically significant differences were determined by t-test, relative to the lite-1(ce314)
control. * p,0.05; *** p,0.001.
doi:10.1371/journal.pone.0043164.g003
Table 2. Promoter combinations used for ASH specific ChR2 expression (Cre-lox system).
Promoter Expression pattern Combinations
psra-6 ASI, ASH, SPDm/
SPVm, PVQ [53]
psra-6::loxP::LacZ::
STOP::loxP::ChR2::mCherry::SL2::GFP
pnhr-79 ADL, ASH [64] pnhr-79::Cre pnhr-79::Cre
posm-10 ASH, ASI,
PHA, PHB [65]
posm-10::loxP::LacZ::
STOP::loxP::ChR2::mCherry::SL2::GFP
posm-10::loxP::LacZ::
STOP::loxP::ChR2::mCherry::SL2::GFP
pgpa-11 ADL, ASH [52] pgpa-11::Cre
No expression Expression, one additional cell
pair in the head (probably ASI)
Expression, one additional cell
pair in the tail (probably PHB)
doi:10.1371/journal.pone.0043164.t002
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showed an expression of GFP in AVA and also a minor expression
in AIY, a pair of neurons which is involved in thermosensation
[50]. Finally, the combination of pflp-18 and pgpa-14 showed
bright expression of GFP in AVA neurons only (Fig. 5C). We
carried out behavioral assays to test the reaction of the three Cre-
loxP AVA lines to blue light illumination (Fig. 5D). As a positive
control we used animals expressing ChR2 in touch neurons (pmec-
4::ChR2). As a negative control, we used lite-1(ce314) animals
expressing no ChR2. 93% of the positive control nematodes
showed a backward movement, i.e. full reversal, not just slowing of
forward locomotion, during or directly after a 1 s blue light
stimulus, while the Cre-loxP lines showed a reaction between 33%
and 73%. The highest reaction was observed in the line with the
pflp-18/pgpa-14 promoter pair, i.e. the one with the AVA specific
ChR2 expression.
To consolidate the blue light reaction of the pflp-18/pgpa-14
animals, we integrated the extrachromosomal array into the
genome. The expression pattern of the bicistronic GFP (Fig. 6A)
again featured fluorescence in AVA neurons. However, we now
observed expression also in the RIG neuron pair [26] (C.
Bargmann, personal communication). RIG neurons are a pair of
interneurons localized in the retrovesicular ganglion, and involved
in reversal behavior [51]. Thus, whole body illumination to
activate ChR2, which evoked reversals in ca. 80% of the animals
tested (Fig. 6B), may affect behavior via RIG as well. However,
GFP expression in RIG was much lower compared to AVA, and
in confocal z-projections, we found no noteworthy expression of
ChR2::mCherry in RIG neurons (Fig. 6A, inset). Thus, the ChR2
expression level in RIG is likely too weak to cause blue light-
evoked behavior. To demonstrate this, we carried out behavioral
Figure 4. Expression pattern and behavioral responses of animals generated towards ChR2 expression in AVA by using FLP
recombinase. A) Fluorescence images of animals expressing ChR2::YFP by using flp-18 and rig-3 promoter pair with the FLP recombinase (top).
Bottom panel shows pflp-18::mCherry expression. Scale bar=20 mm B) Behavioral assay testing withdrawal reactions in response to 470 nm blue
light illumination were as described in Fig. 3D (n$15).
doi:10.1371/journal.pone.0043164.g004
Table 3. Promoter combinations used for AVA specific ChR2 expression (FLP system).
Promoter Expression pattern Combinations
pglr-1 AIB, AVA, AVB, AVD, AVE, AVG, AVJ, DVC, PVC,
PVQ, RIG, RIM, RMD, SMD, PVQ, URY [62]
pglr-1::FRT::mCherry::
STOP::FRT::ChR2::YFP
pglr-1::flp
pgpa-14 ASI, ASJ, ASH, ASK, ADE, PHA, PHB, ALA,
AVA, CAN, DVA, PVQ, RIA, vulva muscles [52]
pgpa-14::flp pgpa-14::FRT::
mCherry::STOP::
FRT::ChR2::YFP
pflp-18 AVA, AIY, RIG, RIM, M2, M3 [66] pflp-18::FRT::
mCherry::STOP::
FRT::ChR2::YFP
pflp-18::flp
prig-3 AVA, I1, I4, M4, NSM, amphid sheath cells [54] prig-3::flp prig-3::FRT::
mCherry::STOP::
FRT::ChR2::YFP
no expression no expression weak in AVA
and M3, RIM
no expression
doi:10.1371/journal.pone.0043164.t003
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photostimulation of AVA or RIG cell bodies separately (Fig. 6C).
The integrated strain ZX1023 pflp-18/pgpa-14 responded with a
decrease of velocity following blue light exposure (470 nm) of
either the body segment harboring AVA neurons only, or to the
whole body. Importantly, there were no marked changes in
velocity following illumination of the segment harboring RIG
neurons (Fig. 6C). Note that for this strain, light intensities
achievable by the tracking and illumination system used did not
allow to induce full reversal behavior to be evoked, while ZX1023
animals clearly responded with full reversals when using a different
microscope (Fig. 6B). We conclude that ChR2 expression in RIG
is too low to evoke obvious behavioral effects after illumination,
and that strain ZX1023 can be used for AVA-specific neuronal
photoactivation.
Discussion
Optogenetic approaches in C. elegans would largely benefit from
generic methods that allow expression of optogenetic tools in single
cells, such that straightforward whole-field illumination can be
used to stimulate just the cell of interest. Such methods, based on
conditional expression at the intersection of two promoters, have
been realized for C. elegans for GFP or other proteins, using FLP or
Cre recombinases [20–22]. In the present study, we used both
systems for expression of ChR2 in several sensory neurons or
interneurons. We thus established functional ‘‘single’’ cell expres-
sion of ChR2 in the AVA neuron pair using the promoters for flp-
18 and gpa-14. Additionally, we tested several promoter combi-
nations targeting PVC as well as ASH neurons, but these attempts
were only partially successful, mainly due to the apparently
incomplete promoter expression patterns reported in the litera-
ture. Nevertheless, single-cell expression in ASH was demonstrat-
Figure 5. Expression pattern and behavioral responses of animals generated towards ChR2 expression in AVA by using Cre
recombinase. GFP fluorescence (confocal stacks) in animals expressing ChR2::mCherry and GFP (bicistronically co-expressed) using the promoter
combinations glr-1 and gpa-14 A), flp-18 and rig-3 B), or flp-18 and gpa-14 C). Scale bar=20 mm. D) Behavioral assay testing withdrawal reactions in
response to 470 nm blue light illumination were as described in Fig. 3D (n=14).
doi:10.1371/journal.pone.0043164.g005
Table 4. Promoter combinations used for AVA specific ChR2 expression (Cre-lox system).
Promoter Expression pattern Combinations
pglr-1 AIB, AVA, AVB, AVD, AVE, AVG, AVJ, DVC, PVC,
PVQ, RIG, RIM, RMD, SMD, PVQ, URY [62]
pglr-1::loxP::LacZ::
STOP::loxP::
ChR2::mCherry::
SL2::GFP
pgpa-14 ASI, ASJ, ASH, ASK, ADE, PHA, PHB, ALA, AVA,
CAN, DVA, PVQ, RIA and vulva muscle cells [52]
pgpa-14::Cre pgpa-14::Cre
pflp-18 AVA, AIY, RIG, RIM, M2, M3 [66] pflp-18::loxP::LacZ::STOP::loxP::
ChR2::mCherry::SL2::GFP
pflp-18::loxP::LacZ::STOP::loxP::
ChR2::mCherry::SL2::GFP
prig-3 AVA, I1, I4, M4, NSM and amphid sheath cells [54] prig-3::Cre
Expression in AVA,
but also in 8
additional cells
Expression in AVA,
but also in additional cells
(probably M3, AIY, RIM)
Single cell expression in
AVA; low expression in
RIG following integration
doi:10.1371/journal.pone.0043164.t004
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combination, and FLP recombinase. We tested these animals in
functional assays, comparing them to other promoter combina-
tions targeting ASH, or single promoter expression via sra-6.
Depending on the promoter combination used, and on relative
expression levels of recombinase and ChR2 construct, both FLP
and Cre systems allowed the generation of useful transgenic lines.
In essence, both methods are very useful, however, considerable
effort in empirically determining the right promoter combination,
and in optimizing expression conditions, may be required.
The most substantial challenge in any of the conditional
expression approaches is to find promoter pairs suited for true cell
specific expression. Most expression patterns reported in the
literature depend on transcriptional promoter-fluorescent protein
fusions, or full-length tagged fusion proteins, some also on
antibody staining [52–54]. Fusion proteins usually produce less
fluorescent signal than expression of just GFP [55–57], and thus it
can be expected that often cells are overlooked or not reported if
they are only weakly expressing the reporter. It is difficult to judge
this from published work, as often fluorescence is shown from a
single focal plane or a select region of the animal [52], making it
impossible to estimate comprehensively the expression pattern of a
particular promoter fragment. Expression patterns may also
change if a given promoter is combined with different coding
sequences, due to possible or cryptic enhancers present in one but
not the other cDNA. Lastly, identifying C. elegans neurons
unequivocally is not a trivial task, so it can be expected that some
neurons are wrongly assigned for a given promoter. Thus, the
most prevalent way of improvement would be to have more
complete and correct expression patterns for C. elegans promoters,
or, ideally, promoter combinations in conditional expression
approaches, as it was pioneered by Zhang et al. (2004) [17].
However, even this information would not guarantee that
expression patterns established this way would be identical if used
to express optogenetic tools. Further manipulation e.g. by genomic
integration of the multicopy tandem array, may alter the achieved
expression patterns, as we observed for expression in AVA:
High(er) expression of Cre may cause unwanted recombination
between distal loxP sites in the tandem array, potentially bringing
ChR2 coding sequence close to a cryptic enhancer sequence,
leading to expression in other cells. In order to better estimate the
finally achieved expression pattern, we used a SL2-bicistronically
expressed GFP, downstream of ChR2::mCherry, leading to strong
GFP expression throughout the cytosol, allowing to detect even
cells with weak expression patterns (Fig. 6A), as described by
Macosco et al. (2009) [20]. In the case of the RIG neuron, which
was well visible by GFP expression, expression of ChR2::mCherry
was hardly detectable and blue-light activation by selective
illumination was so low that no appreciable influence on behavior
could be observed.
Another point to consider is which of the respective two
promoters is used to drive ChR2 expression, and which one for the
recombinase gene. For example, we observed expression of
ChR2::YFP in the pflp-18::FRT::mCherry::STOP::FRT::-
ChR2::YFP + prig-3::FLP animals, but not in the animals of the
opposite combination. Promoter strength influences the efficiency
of expression, and in most cases, it will be desired to achieve as
much ChR2 expression as possible. Therefore, it is favorable to
choose the stronger promoter for ChR2 and the weaker one for
the respective recombinase. The relative amounts of injected DNA
for ChR2 and recombinase construct may also require optimiza-
tion, as this is affecting relative expression levels of the two
transgenes.
The mode of operation of both recombinase systems used (FLP
and Cre) is analogous [21,24]. Some authors reported that the
efficiency of both systems in cultured cells and in mice is
comparable [58–60], while others showed less efficiency of the
FLP system on chromosomal targets [61] and in murine
embryonic stem cells. In our experiments, FLP recombinase
caused no observable expression of ChR2::YFP for most of the
promoter combinations tested, except for the pflp-18 and prig-3
combination. However, behavioral assays were done with these
animals. In comparison to the analogous animals using the Cre
recombinase system, this demonstrated a significantly more
Figure 6. ChR2::mCherry::SL2::GFP expression in AVA (and RIG)
neurons using flp-18 and gpa-14 promoters and Cre recombi-
nase from an integrated transgene. A) Confocal stack showing GFP
fluorescence of the specific expression pattern. Scale bar=100 mm
(20 mm in inset). Inset: Overlay of the ChR2::mCherry (red) and the much
brighter SL2::GFP (green) expression. B) Withdrawal in response to
whole-animal blue illumination, compared in the transgenic line before
(Ex) and after chromosomal integration (Is) was compared after
n o r m a l i z a t i o nt ot h er e s p o n s e so fp mec-4::ChR2 animals tested
alongside. C) Locomotion speed traces of animals of the integrated
strain expressing ChR2 in AVA (and RIG) before, during and after
patterned illumination of either of two different segments in the head
region (blue, segment harboring AVA cell bodies; red, segment
harboring RIG cell bodies, and parts of the AVA axons). In addition,
the whole animal was illuminated (green). Displayed are means 6 SEM
(n$15 in B and C). Duration of the light stimulus is indicated by a blue
bar.
doi:10.1371/journal.pone.0043164.g006
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FLP system – while these animals expressed ChR2 in cells in
addition to AVA. Yet, a different promoter combination, and
using the Cre system, generated more robustly responding animals
expressing ChR2 in AVA neurons. Thus, it depends on the
promoter combination which system is the more efficient one.
We could demonstrate that it is generally possible to establish a
neuron specific ChR2 expression by application of FLP or Cre
recombinase. This significantly expands the possibilities for
neuroscience research in C. elegans, as many more neurons should
now become accessible to single-neuron optogenetic manipula-
tions. Possibly, if more labs adopt these techniques, the joint effort
of the C. elegans researcher community may in the long run
generate a set of animals (or, at least, tested promoter combina-
tions) for essentially every neuron of C. elegans. This would allow
generating or combining strains with different optogenetic
actuators (ChR2, halorhodopsin, proton pumps like Mac or Arch,
as well as color-shifted ChR chimeras like C1V1 [6]) in individual
cells of a given neuronal circuit under study. These could be used
to precisely probe the function of each neuron in the generation of
particular behaviors, or in network function, when using Ca
2+
imaging as a readout [47]. Furthermore, even if single-cell
expression cannot be achieved in all cases, use of multimodal
selective illumination technology for freely behaving animals, as
recently introduced [15,16,46], may allow to achieve single neuron
activation, provided that the neurons expressing ChR2 are located
sufficiently far apart in the animal.
Supporting Information
Figure S1 Fragment reconstitution of genetically split ChR2 and
NpHR opsins in body wall muscle cells. ChR2 and NpHR were
genetically split and resulting N- and C-terminal fragments were
separately co-expressed in body wall muscle cells. Photoactivation
with either blue (for ChR2 fragments) or yellow light (for NpHR
fragments) was applied and resulting behavioral effects (contrac-
tion or relaxation) were measured and compared to the effects
evoked by the respective full-length opsin to test functional
reconstitution. A, B) Schematics of ChR2 (A) and NpHR (B),
depicting heptahelical topology and sites of fragmentation, or YFP
insertion, as indicated by colored arrowheads. Aminoacids
flanking the fragmentation sites are given and contractions
(ChR2) or relaxations (NpHR), respectively, for co-expression
and photostimulation of complementary fragments or full-length
opsins are indicated. Optionally, either the spGFP (green
arrowheads; [32]) or cCFP/nYFP system (yellow arrowheads;
[17]) were applied. When no split fluorophore was used (red
arrowheads), eCFP was added to the C-terminus of NpHR. Where
applicable, putative signal sequences (‘‘sigseq’’; aa 1–27 of ChR2
or aa -19-0 of NpHR [35] were added to the C- (ChR2) or N-
terminal halves (NpHR), respectively, to ensure proper expression
and membrane topology. C) Schematic depicting the arrangement
of split-fluorophores that were optionally added to some
fragmentation sites to visualize and also enforce reconstitution of
fragments (indicated with green and yellow arrowheads in A and
B). Using GFP as described in [32], helices 1–10 were coupled to
the C-terminus of N-terminal opsin fragments and helix 11 was
added to the N-terminus of C-terminal fragments. Alternatively, a
C-terminal fragment of CFP and an N-terminal fragment of YFP
[17] were fused to the C- and N-terminal opsin fragments via
antiparallel leucine zippers. D, E) Photoactivation with either blue
(for ChR2 fragments, D) or yellow light (for NpHR fragments, E)
resulted in behavioral effects (contraction or relaxation) as
measured and compared to the respective full-length opsin to test
functional reconstitution. Displayed are changes in the relative
bodylength after 560 ms of photostimulation; aa=aminoacid,
n.d.=not determined.
(TIF)
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